Page 4 - CANNABIDIOL (CBD) Critical Review Report Geneva, 4-7 June 2018 World Health Organization
P. 4

Cannabidiol (CBD)

                  16.    Illicit Manufacture and Traffic and Related Information................................................. 20

                  17.    Current International Controls and Their Impact ............................................................. 20

                  18.    Current and Past National Controls ................................................................................... 21

                  19.    Other Medical and Scientific Matters Relevant for a Recommendation on the Scheduling
                         of the Substance................................................................................................................... 21

               References ............................................................................................................................................ 22












































































                                                            3
   1   2   3   4   5   6   7   8   9